Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Pharmaceutical company receives notice of noncompliance from NASDAQ
June 6th, 2005
La Jolla Pharmaceutical Company (LJPC) announced it has received notice from the NASDAQ Stock Market indicating that the company is not in compliance with NASDAQ Marketplace Rule 4450(a)(5) (the Minimum Bid Price Rule) because, for the last 30 consecutive business days, the bid price of the company's common stock has closed below the minimum $1.00 per share. In accordance with the NASDAQ Marketplace Rules, the company will be provided 180 calendar days, or until October 24, 2005, to regain compliance with the Minimum Bid Price Rule. This notification has no affect on the listing of the company's common stock at this time. If at any time before...
Source: Biotech Business Week (2005-06-06)
|
